AVJ-301 Clinical Trial: A Clinical Evaluation of AVJ-301 (Absorb™ BVS) in Japanese Population

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 400 participants.

Also called NCT01844284

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 400 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01844284
Other papers using this trial's data
  • A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan European heart journal, 2015-12-14 DOI, PubMed 26330419
  • Bioresorbable Scaffold for Treatment of Coronary Artery Lesions: Intravascular Ultrasound Results From the ABSORB Japan Trial JACC. Cardiovascular interventions, 2018-04-09 DOI, PubMed 29622143
  • Long-Term Outcomes of Absorb Bioresorbable Vascular Scaffold vs. Everolimus-Eluting Metallic Stent - A Randomized Comparison Through 5 Years in Japan Circulation journal : official journal of the Japanese Circulation Society, 2020-04-24 DOI, PubMed 32213737
  • Randomized Comparison Between Everolimus-Eluting Bioresorbable Scaffold and Metallic Stent: Multimodality Imaging Through 3 Years JACC. Cardiovascular interventions, 2020-01-13 DOI, PubMed 31918929

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Japan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01844284. Randomized; single masking; primary purpose treatment. Start 2013-04 (actual); primary completion 2015-01 (actual). Results posted on 2019-02-06.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
AVJ-301 Clinical Trial: A Clinical Evaluation of AVJ-301 (Absorb™ BVS) in Japanese Population
Acronym
ABSORB JAPAN
Condition
Myocardial Ischemia
Intervention (Device)
XIENCE PRIME®/XIENCE Xpedition™
Intervention (Device)
Absorb™ BVS
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct01844284
Content hash
b14fe6f26da323ce53ced604452efe814b1e36091be8b8efad4be1871b3cfd67